UBS Maintains Neutral on Lineage, Lowers Price Target to $36
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice Target
UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:LINE) with a Neutral and lowers the price target from $45 to $36.
UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:LINE) with a Neutral and lowers the price target from $45 to $36.